Low Expression of the Deoxycytidine Kinase (dCK) Gene in a 1-β-D- Arabinofuranosylcytosine-Resistant Human Leukemic Cell Line KY-Ra
- 1 January 1994
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 15 (5-6) , 503-505
- https://doi.org/10.3109/10428199409049755
Abstract
Molecular change of the deoxycytidine kinase (dCK) gene in a 1-beta-D-arabinofuranosylcytosine-resistant human leukemic cell line (KY-Ra) was investigated. KY-Ra showed the same restriction pattern of genomic DNA and the same nucleotide sequences of the dCK gene as the parental cell line. However, the amount of deoxycytidine kinase mRNA was markedly decreased in KY-Ra compared to the parental cell line. This is the first report showing that the down regulation of dCK gene expression may be affected by a different mechanism than mutation.Keywords
This publication has 7 references indexed in Scilit:
- A new myeloblastic leukemia cell line with double minute chromosomes. Induction of methotrexate resistance and dihydrofolate reductase gene amplificationLeukemia Research, 1992
- Cloning and expression of human deoxycytidine kinase cDNA.Proceedings of the National Academy of Sciences, 1991
- Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA PolymeraseScience, 1988
- Cytosine Arabinoside Influx and Nucleoside Transport Sites in Acute LeukemiaJournal of Clinical Investigation, 1982
- Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA.Proceedings of the National Academy of Sciences, 1981
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences, 1977